U.S. Pharma Stock News

Are you trying to figure out whether Sirius XM Holdings stock deserves a spot in your portfolio right now? You are not alone. In a market full of noise and shifting sentiment, SIRI's recent performance has plenty of investors looking for clarity. After all, while most media stocks have had a roller-coaster year, Sirius XM Holdings has seen its share price swing in both directions. Over the past three months, the stock has gained about 7.3%, even as it sits almost 23% lower than a year ago...

In the past week, GameStop drew investor focus as analysts projected very large year-over-year earnings growth and a moderate revenue increase in its upcoming report, following a session where its stock lagged behind the broader market. Heightened attention surrounds GameStop’s shift toward trading cards and collectibles, supported by robust cash reserves and a key partnership with Professional Sports Authenticator (PSA). We’ll explore how GameStop’s business transformation and strong...

On August 18, 2025, PotlatchDeltic Corporation released updated presentation materials outlining its strategy, including capital allocation priorities and opportunities in natural climate solutions such as solar and carbon credits. An important highlight from the update is the company's positioning to leverage both lumber pricing trends and growing demand for sustainable resources within its integrated business model. We'll now examine how PotlatchDeltic's sharpened focus on sustainability...

In the past week, Jackson Financial gained attention after analysts highlighted its strong price momentum, an improved Momentum Score, and a favorable Zacks Rank #2 (Buy) supported by upward earnings estimate revisions. While recent analyst upgrades have drawn investor interest, underlying concerns regarding Jackson’s profitability trends and industry demand present a complex picture for long-term prospects. We'll examine how analyst-driven optimism following recent earnings estimate...

Earlier this week, Baxter International unveiled its new Hemopatch sealing hemostat, a room-temperature collagen pad developed over ten years with direct input from surgeons to improve hemostasis in open and minimally invasive surgeries. The product’s design, shaped by real-world surgical feedback, signals Baxter's focus on creating solutions that address practical clinical challenges in the operating room. We will explore how Hemopatch’s surgeon-driven development could influence Baxter’s...

Recently, under CEO Matt Kissner, John Wiley & Sons reported progress in its Research and Learning segments, highlighting advances in AI licensing agreements and increased partnerships with global technology and research organizations such as Anthropic, Amazon Web Services, and the European Space Agency. Beyond strong operational execution, Wiley’s ability to attract significant journal submissions and collaborate on responsibly integrating AI points to expanding influence in the academic...

Intuitive Surgical (ISRG) is back on many investors’ watchlists after its recent earnings announcement drew attention to its growth trajectory. While there was no headline-grabbing event such as a surprise breakthrough or regulatory twist, the results have sparked some fresh debate about where the company is headed. For investors who have been eyeing the stock, the numbers in this report might feel like a signal to reconsider its prospects, with questions swirling around whether growth will...

Earlier this week, Zacks assigned Ensign Group a Rank #2 (Buy) with a Momentum Style Score of B, highlighting recent upward revisions in earnings estimates and strong price momentum compared to its industry peers. The combination of outperformance versus the sector and marked improvements in analyst outlook has created a mood of increasing positive sentiment around Ensign Group's near-term prospects. Given these favorable earnings forecast changes, we will consider how heightened analyst...

On August 14, 2025, Healthpeak Properties' subsidiary, Healthpeak OP, completed a US$500 million underwritten offering of 4.750% senior notes due 2033, with net proceeds of approximately US$491.4 million intended to repay commercial paper borrowings and for general corporate purposes, including potential acquisitions and capital expenditures. This debt financing enhances Healthpeak's financial flexibility by providing additional liquidity for operational initiatives and potential investments...

Thinking about what to do with your shares in PDD Holdings, or just now weighing up whether to get in? You are far from alone. This is a stock that has captured plenty of attention, swinging up over 31% year-to-date while still showing the scars of a tough 12 months with a nearly 9% drop in total return over the last year. If you zoom out, though, the five-year return sits at a robust 42%. The three-year number is especially head-turning, up over 120%. What contributes to a track record like...

Earlier this month, MDU Resources Group's board raised the quarterly dividend to US$0.14 per share and elected Charles M. Kelley and Tammy J. Miller to its board, with both joining the Audit Committee. The experienced new directors bring expertise in natural gas, utilities, and public policy, aligning with the company's infrastructure growth ambitions and geographic focus. We'll explore how the dividend increase underscores management's focus on shareholder returns and its possible influence...

Over the past two weeks, several clients and partners including MANTECH, Patientory, and RackWare announced collaborations with Oracle to deploy advanced AI, cloud, and healthcare solutions, while Oracle itself introduced a next-generation Health EHR and expanded its integration of leading AI models like OpenAI's GPT-5 and Google Gemini. These developments highlight Oracle's push to become an essential provider of secure, mission-critical AI-driven workflows for enterprises and government...

Centrus Energy Corp. recently completed a US$700 million fixed-income offering of zero coupon senior subordinated unsecured convertible notes due August 15, 2032, with both J.P. Morgan Securities LLC and BofA Securities, Inc. joining as co-lead underwriters. This significant capital raising follows the U.S. Department of Energy's extension of a waiver permitting Centrus Energy to import low enriched uranium from Russia through 2027, supporting stable nuclear fuel supply for U.S. customers...

If you’ve been tracking Pathward Financial (CASH), the news that the company won’t be able to file its quarterly 10-Q with the SEC by the deadline might be a bit of a jolt. Filing delays like this tend to make investors wonder about what’s going on behind the scenes. Are there issues with internal controls, or is it just a paperwork lag? It is the kind of announcement that puts a spotlight on transparency, and often causes the market to reassess the risks around a bank’s fundamentals. Despite...

PennantPark Floating Rate Capital announced in August 2025 that it has formed PennantPark Senior Secured Loan Fund II, a joint venture with a Hamilton Lane-managed fund, targeting middle market loans with an initial $500 million portfolio and combined capital commitments of $200 million from both parties. This collaboration gives Hamilton Lane further access to the middle market credit space and increases its exposure to recurring investment income opportunities from a significant new fund...

Earlier this month, AbbVie announced positive Phase 3 trial results for Rinvoq in severe alopecia areata, demonstrating significantly higher rates of scalp hair coverage compared to placebo, and reported quarterly earnings that exceeded analyst expectations, driven by key product performance and raised annual guidance. This clinical trial milestone and earnings momentum highlight AbbVie's ability to advance its immunology pipeline while continuing to recover from Humira's loss of...

On 22 August 2025, East Buy Holding Limited announced the renewal of its framework agreement with New Oriental Education & Technology Group, extending supply arrangements for private label goods and livestreaming e-commerce products until 31 May 2026 with new annual transaction limits. This renewed agreement highlights anticipated growth in demand and product expansion, as well as ongoing commitment to competitive, market-based pricing between the two partners. We'll now examine how New...

Trying to figure out what to do next with monday.com stock? You are definitely not alone. This workflow software leader has given investors plenty to talk about lately, both for its rollercoaster ride on the charts and for what its numbers suggest might come next. Over the past month, shares dipped sharply, dropping nearly 39%, and they are still down more than 32% over the last year. But here is the twist: in the last day and week, there have been glimmers of green, hinting that risk...

Earlier this month, General Mills filed its definitive proxy statement urging shareholders to vote against two separate shareholder proposals at its upcoming annual meeting, one calling for an independent Board Chair and another seeking disclosure on the results of its regenerative agriculture pesticide reductions. The company’s actions underscore ongoing debates over corporate governance and social responsibility, reflecting increasing shareholder attention to both board leadership...

Rocket Lab announced it is significantly expanding its U.S. semiconductor manufacturing for space-grade components, securing a US$23.9 million CHIPS Act award from the Department of Commerce to boost supply chain security and double wafer production capacity to nearly 35,000 wafers per month. This move strengthens Rocket Lab's role as one of only two U.S. providers of radiation-hardened space-grade semiconductors and supports national security missions by advancing domestic technology...

If you’re watching Bio-Rad Laboratories (BIO) right now, you’re probably sizing up the company’s big reveal: the new EZ-Check Salmonella spp. Kit. This rapid test, designed for quick and reliable detection of Salmonella in food and environmental samples, just picked up significant third-party validations. Both AOAC International and AFNOR have given it the green light, signaling real credibility. With food safety taking center stage globally and regulations tightening up, Bio-Rad’s latest...

Earlier in August 2025, Harrow, Inc. reported strong second quarter results, with quarterly revenue rising to US$63.74 million and net income moving into positive territory, followed by management reaffirming that full-year 2025 revenue is expected to exceed US$280 million. This suggests the company is confident in its growth trajectory, expecting to generate around US$169 million in revenue in the second half to meet its target for the year. We'll examine how Harrow's reaffirmed revenue...

If you are considering what to do with your Lockheed Martin stock, you are in good company. For a company with such an iconic place in America’s defense sector, Lockheed Martin’s share price journey has kept investors both intrigued and cautious over the past year. After a strong multi-year run, the stock is now down nearly 17.5% over the past twelve months, even as the broader market has marched higher. Looking closer, this recent dip may have opened the door for new opportunities,...

Earlier this week, Piper Sandler upgraded Vita Coco Company, noting the beverage company's adaptability in its sourcing strategies to offset tariff impacts. This analyst view highlights Vita Coco's resilience in managing external cost pressures and reinforces the company's capacity for operational adjustment in a challenging global trade environment. Now, we’ll consider how Vita Coco’s sourcing flexibility shapes its investment narrative and long-term prospects for growth and stability. The...